Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

phosphodiesterase 4B

Known as: Cyclic Nucleotide Phosphodiesterases, Type 4B 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Identification of new therapeutic targets may improve the survival rate of patients with colorectal cancer (CRC). Recent studies… Expand
2018
2018
High-fat-diet (HFD) feeding induces adipose dysfunction. This study aims to explore whether the Traditional Chinese Medical… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
Traumatic brain injury (TBI) initiates a deleterious inflammatory response that exacerbates pathology and worsens outcome. This… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
DNA damage is an important contributor to endothelial dysfunction and age-related vascular disease. Recently, we demonstrated in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2016
2016
Learning and memory impairments are common in traumatic brain injury (TBI) survivors. However, there are no effective treatments… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2016
2016
Phosphodiesterase 4 (PDE4) is an adenosine cyclic 3,5-monophosphate-specific degradative enzyme, which is closely associated with… Expand
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 3
Review
2014
Review
2014
Abstract Phosphodiesterase 4B (PDE4B) is a member of the phosphodiesterase family of proteins that plays a critical role in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
OBJECTIVE To observe the preliminary action of phosphodiesterase 4B(PDE4B) in bleomycin-induced pulmonary fibrosis in mice… Expand
2012
2012
Background: Mucus overproduction is a hallmark of otitis media (OM) induced by Streptococcus pneumoniae. Results: PDE4B mediates… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2009
2009
Identification of rational therapeutic targets is an important strategy to improve the cure rate of diffuse large B-cell lymphoma… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5